Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
ACS Medicinal Chemistry Letters
|
July 19, 2011
Screening for GPCR Ligands Using Surface Plasmon Resonance
Iva Navratilova, Jérémy Besnard, Andrew L Hopkins
Nature
|
September 14, 2007
Mission possible
Andrew L Hopkins, Michael J Witty, Solomon Nwaka
Progress in Biophysics and Molecular Biology
|
October 11, 2014
Fragment screening by SPR and advanced application to GPCRs
Claire A Shepherd, Andrew L Hopkins, Iva Navratilova
Drug Discovery Today
|
April 28, 2004
Ligand efficiency: a useful metric for lead selection
Andrew L Hopkins, Colin R Groom, Alexander Alex
Nature Reviews. Drug Discovery
|
December 2, 2006
How many drug targets are there?
John P Overington, Bissan Al-Lazikani, Andrew L Hopkins
Methods of Biochemical Analysis
|
March 22, 2003
Structural bioinformatics in drug discovery
Eric B Fauman, Andrew L Hopkins, Colin R Groom
Current Opinion in Structural Biology
|
January 31, 2006
Can we rationally design promiscuous drugs?
Andrew L Hopkins, Jonathan S Mason, John P Overington
Analytical Biochemistry
|
June 18, 2018
Surveying GPCR solubilisation conditions using surface plasmon resonance
Iva Hopkins Navratilova, Tonia Aristotelous, Louise E Bird, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
The tetrahydrobiopterin pathway and pain
Alasdair M Naylor, Kevin R Pojasek, Andrew L Hopkins, et al.
Drug Discovery Today
|
September 11, 2014
The Joint European Compound Library: boosting precompetitive research
Jérémy Besnard, Philip S Jones, Andrew L Hopkins, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
ACS Medicinal Chemistry Letters
|
July 19, 2011
Screening for GPCR Ligands Using Surface Plasmon Resonance
Iva Navratilova, Jérémy Besnard, Andrew L Hopkins
Nature
|
September 14, 2007
Mission possible
Andrew L Hopkins, Michael J Witty, Solomon Nwaka
Progress in Biophysics and Molecular Biology
|
October 11, 2014
Fragment screening by SPR and advanced application to GPCRs
Claire A Shepherd, Andrew L Hopkins, Iva Navratilova
Drug Discovery Today
|
April 28, 2004
Ligand efficiency: a useful metric for lead selection
Andrew L Hopkins, Colin R Groom, Alexander Alex
Nature Reviews. Drug Discovery
|
December 2, 2006
How many drug targets are there?
John P Overington, Bissan Al-Lazikani, Andrew L Hopkins
Methods of Biochemical Analysis
|
March 22, 2003
Structural bioinformatics in drug discovery
Eric B Fauman, Andrew L Hopkins, Colin R Groom
Current Opinion in Structural Biology
|
January 31, 2006
Can we rationally design promiscuous drugs?
Andrew L Hopkins, Jonathan S Mason, John P Overington
Analytical Biochemistry
|
June 18, 2018
Surveying GPCR solubilisation conditions using surface plasmon resonance
Iva Hopkins Navratilova, Tonia Aristotelous, Louise E Bird, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
The tetrahydrobiopterin pathway and pain
Alasdair M Naylor, Kevin R Pojasek, Andrew L Hopkins, et al.
Drug Discovery Today
|
September 11, 2014
The Joint European Compound Library: boosting precompetitive research
Jérémy Besnard, Philip S Jones, Andrew L Hopkins, et al.
Page
of 5